Related Experiment Video
Updated: Feb 2, 2026
08:31
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
690
A CHAF1B-Dependent Molecular Switch in Hematopoiesis and Leukemia Pathogenesis
Andrew Volk1, Kaiwei Liang2, Praveen Suraneni1
1Division of Hematology/Oncology, Northwestern University, 303 East Superior Street, 5-123, Chicago, IL 60611, USA.
Cancer Cell
|November 14, 2018
Summary
Chromatin assembly factor CHAF1B (p60 subunit) is crucial for normal blood cell development but drives leukemia when overexpressed. Targeting CHAF1B activity suppresses leukemia without harming healthy blood cell formation.
Area of Science:
- Cell Biology
- Molecular Biology
- Hematology
Background:
- The chromatin assembly factor 1 (CAF1) complex, including the p60 subunit CHAF1B, is essential for DNA replication and histone assembly.
- Normal hematopoiesis relies on precise regulation of gene expression and chromatin dynamics.
Purpose of the Study:
- To investigate the role of CHAF1B in hematopoiesis and its potential involvement in leukemogenesis.
- To elucidate the molecular mechanisms by which CHAF1B influences myeloid differentiation and leukemia development.
Main Methods:
- Analysis of CHAF1B function in normal hematopoiesis.
- Investigating the impact of CHAF1B overexpression on leukemia development in vivo.
- Assessing CHAF1B's interaction with chromatin and transcription factors like CEBPA.
- Evaluating therapeutic strategies involving modulation of Chaf1b activity.
Main Results:
- CHAF1B is indispensable for normal hematopoiesis.
- Overexpression of CHAF1B promotes leukemia development.
- CHAF1B interferes with myeloid differentiation by disrupting transcription factor binding, specifically CEBPA.
- Reducing Chaf1b activity, through heterozygous deletion or dominant-negative CAF1 alleles, suppresses leukemogenesis without affecting normal hematopoiesis.
Conclusions:
- CHAF1B plays a dual role in hematopoiesis, being essential for normal development but oncogenic when overexpressed.
- CHAF1B's pro-leukemia activity is mediated by interference with key differentiation transcription factors.
- Targeting CHAF1B represents a potential therapeutic strategy for leukemia.
Related Concept Videos
01:21Hematopoiesis
9.0K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
9.0K
01:20Overview of Hematopoiesis
9.4K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
9.4K
01:22Switching of BJT
861
Switching behavior in Bipolar Junction Transistors (BJTs) is a fundamental aspect utilized in various electronic circuits, particularly for digital logic applications like switches and amplifiers. In a typical switching circuit, a BJT alternates between cut-off and saturation modes, corresponding to the "off" and "on" states, respectively, thus behaving like an ideal switch.
Cut-off Mode ("Off" State): In this state, both the emitter-base and collector-base junctions are...
Cut-off Mode ("Off" State): In this state, both the emitter-base and collector-base junctions are...
861
01:30Pulmonary Hypertension: Classification and Pathogenesis
645
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
645
01:20Asthma: Pathogenesis and Management
1.3K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.3K
01:23Cystic Fibrosis: Pathogenesis
874
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
874